Kaia Health is improving access to care for over 15 million people living with respiratory-related health issues in North America with the launch of its COPD digital therapy

NEW YORK–(BUSINESS WIRE)–Kaia Health, the world’s largest digital therapy company, is dedicated to making high-quality, evidence-based therapies available to everyone, anytime, today announced the availability of the company’s clinically validated virtual offering for chronic obstructive pulmonary disease (COPD) rehabilitation. The North American rollout builds on the company’s already established success in researching, developing and launching the app in Germany and the promising results of a randomized controlled trial (RCT) recently published in Thorax.

COPD refers to a group of conditions that cause airflow blockage and breathing problems, including emphysema and chronic bronchitis. According to the Centers for Disease Control and Prevention, nearly 15.7 million Americans (6.4%) reported being diagnosed with COPD, which was the fourth leading cause of death in the United States in 2018. there is no cure for the disease, COPD can be treated using digital therapeutic pulmonary rehabilitation (PR) solutions like those developed by Kaia Health. There is also clinical evidence that suggests PR can be used to treat long-lasting symptoms of COVID-19.

PR is considered important for COPD patients to improve their quality of life and exercise capacity, but in many cases it is difficult to access. Currently, PR is offered in-person at outpatient clinics, but is generally limited to metropolitan areas. A 2021 study by the University of Alabama Pulmonary Center found that the average distance between COPD patients and their nearest PR center was, on average, 8.6 miles in areas metropolitan areas, 20.0 miles in micropolitan or suburban areas and 26.6 miles in small urban/rural areas. By providing an easily accessible virtual public relations solution for patients, Kaia Health is improving access to care and reducing the barrier to integrating exercise into patients’ lives. At the same time, it provides a training program that helps patients manage their COPD condition and maintain their level of physical activity.

The Kaia COPD app can also significantly reduce costs for payers. According to a study published in the International Journal of Chronic Obstructive Pulmonary Disease, total annual health care expenditure was 3 times higher for patients with COPD than for patients without, with direct medical costs associated with the disease amounting to $32 billion and indirect costs $20.4 billion billions of dollars.

Built on the Kaia Health digital therapy platform, the Kaia Health COPD app digitizes and delivers affordable and accessible physical PR, considered the gold standard in COPD, right to patients’ homes on their smartphones. It is available anytime and anywhere, without requiring hospitalization or a visit to a health facility.

“As the world’s largest digital therapy company in all conditions, Kaia Health is on a mission to break down barriers and provide high-quality, affordable and accessible care for everyone. I am so proud that we have been able to expand our digital therapy platform to now help COPD patients as well as those struggling with musculoskeletal issues,” said Nigel Ohrenstein, President of Kaia Health. “Maintaining physical activity in patients with COPD has been shown to reduce readmissions while increasing overall survival rates. Today, we are leading the industry in delivering a new treatment option that improves patient health and quality of life.

Kaia Health’s COPD app is the market leader in comprehensive digital pulmonary rehabilitation and has recently been clinically validated via an RCT conducted by physicians from the rehabilitation centers of Zurich and the University of Marburg. The scientific study, the first of its kind, examined how the use of Kaia Health affects physical activity after hospital treatment. As a result, researchers found that with Kaia Health, improvements in patient health from inpatient rehabilitation were maintained at rates well above those of the control group for the duration of the study. of 6 months. The study also demonstrated that using Kaia Health significantly reduces the overall severity of symptoms.

To learn more about how Kaia Health can enable healthcare organizations to minimize the impact of chronic diseases, including COPD as well as musculoskeletal pain, while reducing medical expenses, please visit: https ://kaiahealth.com/ to schedule a demo or contact directly at [email protected].

About Kaia Health

Kaia Health is the world’s largest digital therapy company creating accessible, evidence-based treatments for a range of conditions, including musculoskeletal pain and COPD. Kaia Health spans 60 million lives worldwide, and its clinically proven motion analysis capability is transforming and democratizing healthcare through technology that patients can access anytime, anywhere, with the camera of their smartphone or tablet. Kaia Health is the most clinically validated digital MSK provider, and its motion analysis technology is as accurate as physiotherapists in suggesting exercise corrections, resulting in equitable care regardless of BMI, body weight, and weight. age, sex or location. Kaia Health is a member of the Digital Therapeutics Alliance (DTA) and has offices in New York and Munich. Learn more at www.kaiahealth.com.

About John Tuttle

Check Also

Non-pharmacological treatments outperform opioid treatment for patients with chronic non-surgical pain

Updated prescribing guidelines published in 2014 and 2016 may explain a lower opioid use of …